0001104659-15-047286.txt : 20150624 0001104659-15-047286.hdr.sgml : 20150624 20150624160542 ACCESSION NUMBER: 0001104659-15-047286 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150624 ITEM INFORMATION: Material Impairments ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20150624 DATE AS OF CHANGE: 20150624 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HCP, INC. CENTRAL INDEX KEY: 0000765880 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 330091377 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08895 FILM NUMBER: 15949272 BUSINESS ADDRESS: STREET 1: 1920 MAIN STREET STREET 2: SUITE 1200 CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 949-407-0700 MAIL ADDRESS: STREET 1: 1920 MAIN STREET STREET 2: SUITE 1200 CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: HEALTH CARE PROPERTY INVESTORS INC DATE OF NAME CHANGE: 19920703 8-K 1 a15-14649_18k.htm 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

June 24, 2015

Date of Report (Date of earliest event reported)

 


 

HCP, Inc.

(Exact name of registrant as specified in its charter)

 


 

 

Maryland

 

001-08895

 

33-0091377

(State of Incorporation)

 

(Commission File Number)

 

(IRS Employer Identification Number)

 

1920 Main Street, Suite 1200

Irvine, CA 92614

(Address of principal executive offices) (Zip Code)

 

(949) 407-0700

(Registrant’s telephone number, including area code)

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 


 



 

Item 2.06             Material Impairments

 

On June 24, 2015, HCP, Inc. (the “Company”) determined that its investment in 12.25% senior unsecured notes due 2020 (the “Notes”) issued by Elli Investments Limited (“Elli”), a subsidiary of Terra Firma, as part of the financing for Elli’s acquisition of Four Seasons Health Care (“Four Seasons”), is impaired. The Company purchased an aggregate par value of £138.5 million of the Notes at a discount for £136.8 million in June 2012, representing 79% of the total £175 million issued and outstanding Notes. The Company determined that there is an other-than-temporary decrease in the estimated fair value of the Notes resulting from significant deterioration in Four Seasons’ operating performance since the fourth quarter of 2014. This decline in performance is due to (i) increased labor and central corporate costs; (ii) elevated levels of care home embargoes; and (iii) lower occupancy due to an above-average winter death rate during the first quarter of 2015. Accordingly, the Company expects to record a non-cash impairment charge in the second quarter of 2015 of approximately $42 million, or $0.09 per diluted share, reducing the carrying value of the Company’s Notes to an estimated $174 million (£111 million). Elli remains obligated to repay the aggregate par value of the Notes at maturity, including interest payments due June 15 and December 15 each year, is current on its contractual interest payments and is in compliance with its obligations under the Notes.

 

Four Seasons is the largest elderly and specialist care provider in the United Kingdom, operating approximately 470 care homes and specialist care centers located throughout the United Kingdom. As of March 31, 2015, Elli owned a freehold interest in over 50% of its facilities under management and had £86.7 million of cash on hand. In addition to the £175 million of Notes described above, Elli has debt obligations of £350 million of 8.75% senior secured notes due 2019 and a £40 million secured term loan due 2017.

 

Item 7.01              Regulation FD Disclosure

 

Updated Guidance for Full Year 2015

 

The Company is updating its full year 2015 guidance solely to reflect the impact of the estimated non-cash impairment charge described above and the previously announced severance charge of $0.015 per diluted share in connection with the resignation of the Company’s Executive Vice President and Chief Investment Officer. The updated guidance does not reflect the impact of future unannounced acquisitions and dispositions, and is as follows: the Company expects Funds From Operations (“FFO”) per share to range between $1.92 and $1.98 and earnings per share to range between $0.74 and $0.80. Excluding the charges described above, the Company continues to expect full year 2015 FFO as adjusted per share to range between $3.09 and $3.15 and Funds Available for Distribution (“FAD”) per share to range between $2.66 and $2.72.

 

FFO, FFO as adjusted and FAD are supplemental non-GAAP financial measures that the Company believes are useful in evaluating the operating performance of real estate investment trusts. A reconciliation of these non-GAAP financial measures to GAAP earnings per share is included as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

 

The information disclosed under this Item 7.01, including Exhibit 99.1 hereto, is being furnished to the Securities and Exchange Commission (“SEC”), and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any filing with the SEC under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference therein.

 

Forward-Looking Statements

 

The statements contained in this Form 8-K that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These statements include, among other things, the Company’s expectations with respect to (i) net income, FFO, FFO as adjusted and FAD applicable to common shares on a diluted basis for the full year of 2015; and (ii) the Company’s expectations with respect to its investment in the Notes. These statements are made as of the date hereof, are not guarantees of future performance and are subject to known and unknown risks, uncertainties, assumptions and other factors—many of which are out of the Company and its management’s control and difficult to forecast—that could cause actual results to differ materially from those set forth in or implied by such forward-looking statements. These risks and uncertainties include but are not limited to: our reliance on a concentration of a small number of tenants and operators for a significant portion of our revenues; the financial

 

1



 

weakness of tenants and operators, including potential bankruptcies and downturns in their businesses, which results in uncertainties regarding the Company’s ability to continue to realize the full benefit of such tenants’ and/or operators’ leases; the ability of our tenants and operators to conduct their respective businesses in a manner sufficient to maintain or increase their revenues and to generate sufficient income to make their rent and loan payments and the Company’s ability to recover investments made, if applicable, in their operations; competition for tenants and operators, including with respect to new leases and mortgages and the renewal or rollover of existing leases; availability of suitable properties to acquire at favorable prices and the competition for the acquisition and financing of those properties; the Company’s ability to negotiate the same or better terms with new tenants or operators if existing leases are not renewed or the Company exercises its right to replace an existing tenant or operator upon default; the risks associated with the Company’s investments in joint ventures and unconsolidated entities, including its lack of sole decision making authority and reliance on its partners’ financial condition and continued cooperation; the risk that the Company may not be able to achieve the benefits of investments, including our investment in the Notes, within expected time frames or at all, or within expected cost projections; the potential impact of future litigation matters, including the possibility of larger than expected litigation costs, adverse results and related developments; the effect on healthcare providers of legislation addressing entitlement programs and related services, including Medicare and Medicaid, which may result in future reductions in reimbursements; changes in federal, state or local laws and regulations, including those affecting the healthcare industry that affect the Company’s costs of compliance or increase the costs, or otherwise affect the operations, of its tenants and operators; volatility or uncertainty in the capital markets, the availability and cost of capital as impacted by interest rates, changes in the Company’s credit ratings, and the value of its common stock, and other conditions that may adversely impact its ability to fund its obligations or consummate transactions, or reduce the earnings from potential transactions; changes in global, national and local economic conditions, and currency exchange rates; changes in the credit ratings on United States (“U.S.”) government debt securities or default or delay in payment by the U.S. of its obligations; the Company’s ability to manage our indebtedness level and changes in the terms of such indebtedness; the ability to maintain the Company’s qualification as a real estate investment trust; and other risks and uncertainties described from time to time in the Company’s Securities and Exchange Commission filings, including its 2014 Annual Report on Form 10-K and quarterly reports on Form 10-Q. The Company assumes no, and hereby disclaims any, obligation to update any of the foregoing or any other forward-looking statements as a result of new information or new or future developments, except as otherwise required by law. These statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of this Form 8-K.

 

Item 9.01              Financial Statements and Exhibits.

 

(d)           Exhibit.  The following exhibit is being furnished herewith:

 

No.

 

Description

 

 

 

99.1

 

Reconciliation of HCP, Inc.’s projected FFO, FFO as adjusted and FAD per share to GAAP earnings per share for full year 2015

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Exchange Act, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

 

HCP, INC.

 

 

(Registrant)

 

 

 

Date: June 24, 2015

By:

/s/ Timothy M. Schoen

 

 

Timothy M. Schoen

 

 

Executive Vice President and Chief Financial Officer

 

3



 

EXHIBIT INDEX

 

No.

 

Description

 

 

 

99.1

 

Reconciliation of HCP, Inc.’s projected FFO, FFO as adjusted and FAD per share to GAAP earnings per share for full year 2015

 

4


EX-99.1 2 a15-14649_1ex99d1.htm EX-99.1

Exhibit 99.1

 

HCP, Inc.

Reconciliation of projected FFO, FFO as adjusted and FAD per share

to GAAP earnings per share

 

 

 

Full Year 2015(1)

 

 

 

Low

 

High

 

 

 

 

 

 

 

Diluted earnings per common share

 

$

0.74

 

$

0.80

 

Real estate depreciation and amortization

 

1.07

 

1.07

 

Other depreciation and amortization

 

0.05

 

0.05

 

Gain on sales of real estate

 

(0.01)

 

(0.01)

 

Joint venture FFO adjustments

 

0.07

 

0.07

 

Diluted FFO per common share

 

$

1.92

 

$

1.98

 

Other impairments(2)

 

1.12

 

1.12

 

Transaction-related items

 

0.04

 

0.04

 

Severance-related charge(3)

 

0.01

 

0.01

 

Diluted FFO as adjusted per common share

 

$

3.09

 

$

3.15

 

Amortization of net below market lease intangibles and deferred revenues

 

(0.01)

 

(0.01)

 

Amortization of deferred compensation

 

0.05

 

0.05

 

Amortization of deferred financing costs, net

 

0.04

 

0.04

 

Straight-line rents

 

(0.06)

 

(0.06)

 

DFL accretion

 

(0.18)

 

(0.18)

 

Other depreciation and amortization

 

(0.05)

 

(0.05)

 

Leasing costs and tenant and capital improvements

 

(0.18)

 

(0.18)

 

Lease restructure payments

 

0.05

 

0.05

 

Joint venture adjustments – CCRC entrance fees

 

0.06

 

0.06

 

Joint venture and other FAD adjustments

 

(0.15)

 

(0.15)

 

Diluted FAD per common share

 

$

2.66

 

$

2.72

 

 

 

 

 

(1)          Except as otherwise noted above, the foregoing projections reflect management’s view of current and future market conditions, including assumptions with respect to rental rates, occupancy levels, development items and the earnings impact of the events referenced in this filing. Except as otherwise noted, these estimates do not reflect the potential impact of future acquisitions, dispositions, other impairments or recoveries, the future bankruptcy or insolvency of our operators, lessees, borrowers or other obligors, the effect of any future restructuring of our contractual relationships with such entities, gains or losses on marketable securities, ineffectiveness related to our cash flow hedges, or existing and future litigation matters including the possibility of larger than expected litigation costs and related developments. There can be no assurance that our actual results will not differ materially from the estimates set forth above. The aforementioned ranges represent management’s best estimates based upon the underlying assumptions as of the date of this filing. Except as otherwise required by law, management assumes no, and hereby disclaims any, obligation to update any of the foregoing projections as a result of new information or new or future developments.

 

(2)          On June 24, 2015, we determined our investment in Four Seasons Health Care senior unsecured notes is impaired, resulting in an expected non-cash impairment charge of $0.09 per diluted share in the second quarter of 2015. The remaining $1.03 per diluted share impact represents our previously announced non-cash impairment charge in the first quarter of 2015 related to our direct financing lease (“DFL”) investments with HCR ManorCare, Inc.

 

(3)          As a result of the resignation of HCP’s Executive Vice President and Chief Investment Officer, we expect to record a severance-related charge of $0.015 per diluted share in the second quarter of 2015.

 

We believe Funds From Operations (“FFO”) is an important supplemental measure of operating performance for a real estate investment trust (“REIT”). Because the historical cost accounting convention used for real estate assets utilizes straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen and fallen with market conditions, presentations of operating results for a REIT that use historical cost accounting for depreciation could be less informative. The term FFO was developed by the REIT industry to address this issue. FFO as defined by the National Association of Real Estate Investment Trusts (“NAREIT”) is net (loss) income applicable to common shares (computed in accordance with U.S. generally accepted accounting principles or “GAAP”), excluding gains or losses from sales of property, impairments of, or related to, depreciable real estate, plus real estate, DFL and other depreciation and amortization, and after adjustments for joint ventures. Adjustments for joint ventures are calculated to reflect FFO on the same basis. FFO does not represent

 



 

cash generated from operating activities determined in accordance with GAAP, is not necessarily indicative of cash available to fund cash needs and should not be considered an alternative to net income. We compute FFO in accordance with the current NAREIT definition; however, other REITs may report FFO differently or have a different interpretation of the current NAREIT definition from ours. FFO as adjusted represents FFO before the impact of impairments (recoveries) of non-depreciable assets, transaction-related items (defined below) and severance-related charges. Transaction-related items include acquisition and pursuit costs (e.g., due diligence and closing) and gains/charges incurred as a result of mergers and acquisitions and lease amendment or termination activities. Management believes that FFO as adjusted provides a meaningful supplemental measurement of our FFO run-rate. This measure is a modification of the NAREIT definition of FFO and should not be used as an alternative to net income (determined in accordance with GAAP) or NAREIT FFO.

 

Funds Available for Distribution (“FAD”) is defined as FFO as adjusted after excluding the impact of the following: (i) amortization of acquired market lease intangibles, net; (ii) amortization of deferred compensation expense; (iii) amortization of deferred financing costs, net; (iv) straight-line rents; (v) accretion and depreciation related to DFLs and lease incentive amortization (reduction of straight-line rents); and (vi) deferred revenues, excluding amounts amortized into rental income that are associated with tenant funded improvements owned/recognized by us and up-front cash payments made by tenants to reduce their contractual rents. Also, FAD is: (i) computed after deducting recurring capital expenditures, including leasing costs and second generation tenant and capital improvements; and (ii) includes lease restructure payments and adjustments to compute our share of FAD from our unconsolidated joint ventures and those related to continuing care retirement community (“CCRC”) non-refundable entrance fees. Other REITs or real estate companies may use different methodologies for calculating FAD, and accordingly, our FAD may not be comparable to those reported by other REITs. Although our FAD computation may not be comparable to that of other REITs, management believes FAD provides a meaningful supplemental measure of our performance and is frequently used by analysts, investors, and other interested parties in the evaluation of our performance as a REIT. FAD does not represent cash generated from operating activities determined in accordance with GAAP, is not necessarily indicative of cash available to fund cash needs, and should not be considered as an alternative to net income determined in accordance with GAAP.